Mount Desert Island Biological Lab’s scientists: Kevin Strange, Voot Yin and their collaborator Michael Zasloff have been awarded a patent for MSI-1436, a potential new heart disease drug that stimulates the repair and regeneration of heart tissue damaged by injuries like a heart attack, according to MaineBiz. This is the first patent for the lab. Prof. Kevin Strange, MDIBL’s president says: “The importance of this achievement cannot be overstated. This patent is a critical step forward in our ability to develop new treatments for those who suffer from heart disease (…)”. Read full story
MDI Biological Lab Earns Its First Patent For Heart Repair Medicine
Related Posts
Maine’s startup ‘mojo’ highlighted in national ranking
As a place to start a business, Maine’s “mojo” is going strong, as shown in a new national ranking released Tuesday by WalletHub,...
Maine CDC Director Nirav Shah to join U.S. CDC leadership
Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention, has been appointed principal deputy director at the...
$5.6M in state funding to support Maine startups, entrepreneurs
Sixteen Maine organizations helping startups and entrepreneurs will share $5.6 million in state funding from the Pandemic Recovery for an Innovative Maine...